Skip to main content

Table 2 Share of positive recommendations and reimbursement decisions in analysed countries with respect to the type of approval

From: Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

Country

Approval type

Recommendation

Reimbursement

Total

Positive

Negative

No recommendation

Reimbursed

Not reimbursed

Bulgaria

Conditional approval

2 (22.22%)

0 (0%)

7 (77.78%)

2 (22.22%)

7 (77.78%)

9

 

Exceptional circumstances

1 (50%)

0 (0%)

1 (50%)

1 (50%)

1 (50%)

2

 

Unconditional

10 (40%)

0 (0%)

15 (60%)

10 (40%)

15 (60%)

25

 

Total

13 (36.11%)

0 (0%)

23 (63.89%)

13 (36.11%)

23 (63.89%)

36

Croatia

Conditional approval

1 (11.11%)

0 (0%)

8 (88.89%)

2 (22.22%)

7 (77.78%)

9

 

Exceptional circumstances

0 (0%)

0 (0%)

2 (100%)

0 (0%)

2 (100%)

2

 

Unconditional

9 (36%)

0 (0%)

16 (64%)

6 (24%)

19 (76%)

25

 

Total

10 (27.78%)

0 (0%)

26 (72.22%)

8 (22.22%)

28 (77.78%)

36

Czechia

Conditional approval

0 (0%)

0 (0%)

9 (100%)

0 (0%)

9 (100%)

9

 

Exceptional circumstances

1 (50%)

0 (0%)

1 (50%)

0 (0%)

2 (100%)

2

 

Unconditional

10 (40%)

0 (0%)

15 (60%)

10 (40%)

15 (60%)

25

 

Total

11 (30.56%)

0 (0%)

25 (69.44%)

10 (27.78%)

26 (72.22%)

36

Estonia

Conditional approval

2 (22.22%)

0 (0%)

7 (77.78%)

2 (22.22%)

7 (77.78%)

9

 

Exceptional circumstances

0 (0%)

0 (0%)

2 (100%)

0 (0%)

2 (100%)

2

 

Unconditional

11 (44%)

0 (0%)

14 (56%)

11 (44%)

14 (56%)

25

 

Total

13 (36.11%)

0 (0%)

23 (63.89%)

13 (36.11%)

23 (63.89%)

36

Hungary

Conditional approval

2 (22.22%)

1 (11.11%)

6 (66.67%)

2 (22.22%)

7 (77.78%)

9

 

Exceptional circumstances

1 (50%)

0 (0%)

1 (50%)

1 (50%)

1 (50%)

2

 

Unconditional

9 (36%)

4 (16%)

12 (48%)

9 (36%)

16 (64%)

25

 

Total

12 (33.33%)

5 (13.89%)

19 (52.78%)

12 (33.33%)

24 (66.67%)

36

Latvia

Conditional approval

1 (11.11%)

0 (0%)

8 (88.89%)

1 (11.11%)

8 (88.89%)

9

 

Exceptional circumstances

0 (0%)

1 (50%)

1 (50%)

0 (0%)

2 (100%)

2

 

Unconditional

3 (12%)

3 (12%)

19 (76%)

3 (12%)

22 (88%)

25

 

Total

4 (11.11%)

4 (11.11%)

28 (77.78%)

4 (11.11%)

32 (88.89%)

36

Lithuania

Conditional approval

0 (0%)

0 (0%)

9 (100%)

0 (0%)

9 (100%)

9

 

Exceptional circumstances

0 (0%)

0 (0%)

2 (100%)

0 (0%)

2 (100%)

2

 

Unconditional

10 (40%)

0 (0%)

15 (60%)

10 (40%)

15 (60%)

25

 

Total

10 (27.78%)

0 (0%)

26 (72.22%)

10 (27.78%)

26 (72.22%)

36

Poland

Conditional approval

2 (22.22%)

3 (33.33%)

4 (44.44%)

2 (22.22%)

7 (77.78%)

9

 

Exceptional circumstances

1 (50%)

0 (0%)

1 (50%)

1 (50%)

1 (50%)

2

 

Unconditional

8 (32%)

9 (36%)

8 (32%)

12 (48%)

13 (52%)

25

 

Total

11 (30.56%)

12 (33.33%)

13 (36.11%)

15 (41.67%)

21 (58.33%)

36

Romania

Conditional approval

1 (11.11%)

0 (0%)

8 (88.89%)

1 (11.11%)

8 (88.89%)

9

 

Exceptional circumstances

1 (50%)

0 (0%)

1 (50%)

1 (50%)

1 (50%)

2

 

Unconditional

6 (24%)

0 (0%)

19 (76%)

7 (28%)

18 (72%)

25

 

Total

8 (22.22%)

0 (0%)

28 (77.78%)

9 (25%)

27 (75%)

36

Slovakia

Conditional approval

0 (0%)

1 (11.11%)

8 (88.89%)

0 (0%)

9 (100%)

9

 

Exceptional circumstances

0 (0%)

0 (0%)

2 (100%)

0 (0%)

2 (100%)

2

 

Unconditional

10 (40%)

2 (8%)

13 (52%)

10 (40%)

15 (60%)

25

 

Total

10 (27.78%)

3 (8.33%)

23 (63.89%)

10 (27.78%)

26 (72.22%)

36

  1. Unconditional means that neither conditional approval nor exceptional circumstances were granted